We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The company is launching a kit that includes the device and a tablet computer that is pre-configured for access to the cloud-based VirtualCare telemedicine platform. Read More
The FDA has also granted Enhertu an accelerated approval for treatment of this specific NSCLC patient population who have received a prior systemic therapy. Read More
The test first received FDA approval in April 2021 for assessing the eligibility of patients with endometrial cancer for treatment with GSK’s Jemperli. Read More